Infinity Pharmaceuticals
Listing Websites about Infinity Pharmaceuticals
Infinity Pharmaceuticals - INFI Stock Forecast, Price
(6 days ago) Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally …
Url: Visit Now
Category: Pharmaceutical, Cancer Detail Drugs
Infinity Pharmaceuticals, Inc. (INFI) - Yahoo!
(6 days ago) Find the latest Infinity Pharmaceuticals, Inc. (INFI) stock quote, history, news and other vital information to help you with your stock trading and investing.
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Infinity Pharmaceuticals (NASDAQ:INFI) Stock Crosses …
(1 days ago) The stock has a two hundred day moving average of $0.93 and traded as high as $1.24. Infinity Pharmaceuticals shares last traded at $1.16, with a volume of 275,766 shares …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Infinity Pharmaceuticals - IPI
(5 days ago) Infinity Reports Clinical and Translational Data from Expansion Cohorts of MARIO‑1 Phase 1b Study of IPI-549 in Combination with Opdivo® (nivolumab) at SITC's 33rd Annual Meeting
Url: Visit Now
Category: Health Detail Drugs
Infinity Laboratories
(7 days ago) Infinity Laboratories is a powerful network of state-of-the-art testing facilities that are FDA Registered, ISO 17025 Accredited, and DEA licensed. With an enhanced focus in the areas of …
Url: Visit Now
Category: Health Detail Drugs
Infinity Pharmaceuticals Stock Forecast - StockInvest.us
(3 days ago) Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally …
Url: Visit Now
Category: Pharmaceutical, Cancer Detail Drugs
INFI Infinity Pharmaceuticals Inc. — Stock Price and …
(4 days ago) INFI Infinity Pharmaceuticals Inc. — Stock Price and Discussion Stocktwits. 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. Infinity …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Infinity Pharmaceuticals LinkedIn
(6 days ago) Infinity Pharmaceuticals, Inc., is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Infinity Pharmaceuticals, Inc. (INFI) - Yahoo!
(4 days ago) Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered …
Url: Visit Now
Category: Pharmaceutical, Cancer Detail Drugs
INFI: Infinity Pharmaceuticals Inc - Stock Price, Quote and News
(2 days ago) Infinity Pharmaceuticals, Inc. clinical-stage biopharmaceutical company that is focused on developing medicines for people with cancer. The Company is focused on advancing …
Url: Visit Now
Category: Pharmaceutical, Cancer Detail Drugs
› Medical school ranking world
› Texas gulf coast medical center
› Kroger pharmacy insurance plans
› Food establishment employee health policy
› University of nashville medical school
› Beth israel deaconess medical center gateway
Recently Searched› Memorial health pembroke pines florida
› Spectrum health patient complaints
› Elmhurst hospital new york city
› San luis obispo public health department
› Southern village pharmacy chapel hill
› St francis medical center cape
› Dryer vent rerouting harbor city drug
› Pro universal health care article
› Masters to medical school program
FAQ about Infinity Pharmaceuticals
Where can I buy Infinity Pharmaceuticals' stock?
Shares of INFI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Infinity Pharmaceuticals' stock price today?
What currency is used in Infinity Pharmaceuticals?
Currency in USD. Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer.
What was the earnings release for Infiniti pharmaceuticals (Infi)?
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) posted its quarterly earnings data on Tuesday, November, 2nd. The biotechnology company reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.02.
What are Wall Street analysts' target prices for Infinity Pharmaceuticals' stock?
3 Wall Street research analysts have issued 12 month target prices for Infinity Pharmaceuticals' stock. Their INFI share price forecasts range from $3.00 to $9.00. On average, they predict the company's share price to reach $5.25 in the next year. This suggests a possible upside of 252.3% from the stock's current price.